Neuropsychological Profiles of Patients with Progressive Apraxia of Speech and Aphasia.
Agrammatic aphasia
Frontotemporal dementia
Motor speech disorder
Nonfluent primary progressive aphasia
Primary progressive aphasia
Primary progressive apraxia of speech
Journal
Journal of the International Neuropsychological Society : JINS
ISSN: 1469-7661
Titre abrégé: J Int Neuropsychol Soc
Pays: England
ID NLM: 9503760
Informations de publication
Date de publication:
05 2022
05 2022
Historique:
pubmed:
23
7
2021
medline:
14
5
2022
entrez:
22
7
2021
Statut:
ppublish
Résumé
To characterize and compare the neuropsychological profiles of patients with primary progressive apraxia of speech (PPAOS) and apraxia of speech with progressive agrammatic aphasia (AOS-PAA). Thirty-nine patients with PPAOS and 49 patients with AOS-PAA underwent formal neurological, speech, language, and neuropsychological evaluations. Cognitive domains assessed included immediate and delayed episodic memory (Wechsler Memory Scale-Third edition; Logical Memory; Visual Reproduction; Rey Auditory Verbal Learning Test), processing speed (Trail Making Test A), executive functioning (Trail Making Test B; Delis-Kaplan Executive Functioning Scale - Sorting), and visuospatial ability (Rey-Osterrieth Complex Figure copy). The PPAOS patients were cognitively average or higher in the domains of immediate and delayed episodic memory, processing speed, executive functioning, and visuospatial ability. Patients with AOS-PAA performed more poorly on tests of immediate and delayed episodic memory and executive functioning compared to those with PPAOS. For every 1 unit increase in aphasia severity (e.g. mild to moderate), performance declined by 1/3 to 1/2 a standard deviation depending on cognitive domain. The degree of decline was stronger within the more verbally mediated domains, but was also notable in less verbally mediated domains. The study provides neuropsychological evidence further supporting the distinction of PPAOS from primary progressive aphasia and should be used to inform future diagnostic criteria. More immediately, it informs prognostication and treatment planning.
Identifiants
pubmed: 34289926
pii: S1355617721000692
doi: 10.1017/S1355617721000692
pmc: PMC8986341
mid: NIHMS1787400
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
441-451Subventions
Organisme : NIA NIH HHS
ID : R01 AG041851
Pays : United States
Organisme : NIDCD NIH HHS
ID : R01 DC014942
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG034676
Pays : United States
Organisme : NIA NIH HHS
ID : P50 AG016574
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG049810
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG054449
Pays : United States
Organisme : NINDS NIH HHS
ID : R21 NS094489
Pays : United States
Organisme : NIA NIH HHS
ID : U19 AG063911
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG011378
Pays : United States
Organisme : NIDCD NIH HHS
ID : R01 DC012519
Pays : United States
Organisme : NINDS NIH HHS
ID : R21 NS094684
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS089544
Pays : United States
Organisme : NIA NIH HHS
ID : U01 AG006786
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG050603
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS089757
Pays : United States
Organisme : NIDCD NIH HHS
ID : R01 DC010367
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS097495
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG062677
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG037491
Pays : United States
Références
Cortex. 2018 Feb;99:358-374
pubmed: 29353121
J Speech Lang Hear Res. 2018 Sep 19;61(9):2337-2346
pubmed: 30098169
Eur J Neurol. 2021 Jun;28(6):1801-1811
pubmed: 33662165
J Speech Lang Hear Res. 2012 Oct;55(5):S1518-22
pubmed: 23033445
Ann Neurol. 2001 Apr;49(4):425-32
pubmed: 11310619
Mov Disord. 2007 Jan;22(1):41-7
pubmed: 17115387
Neurology. 2011 Mar 15;76(11):1006-14
pubmed: 21325651
J Int Neuropsychol Soc. 2018 Mar;24(3):259-268
pubmed: 29039275
Continuum (Minneap Minn). 2019 Feb;25(1):101-127
pubmed: 30707189
Neurology. 2010 Jan 5;74(1):42-9
pubmed: 19940270
Eur J Neurol. 2018 Nov;25(11):1352-1357
pubmed: 29935044
Mov Disord. 2017 Jun;32(6):853-864
pubmed: 28467028
N Engl J Med. 2003 Oct 16;349(16):1535-42
pubmed: 14561797
Neuroimage Clin. 2018 Mar 03;18:617-629
pubmed: 29845010
Brain. 2019 Aug 1;142(8):2466-2482
pubmed: 31199471
Neurology. 2013 Jul 23;81(4):337-45
pubmed: 23803320
Am J Speech Lang Pathol. 2015 May;24(2):88-100
pubmed: 25654422
J Int Neuropsychol Soc. 2015 Jul;21(6):429-35
pubmed: 26067425
Am J Speech Lang Pathol. 2018 Nov 21;27(4):1303-1318
pubmed: 30458509
Arch Clin Neuropsychol. 1999 Aug;14(6):481-7
pubmed: 14590575
Neurology. 2013 Jan 29;80(5):496-503
pubmed: 23359374
Aphasiology. 2014 Aug;28(8-9):1004-1017
pubmed: 25309017
Brain. 2006 Jun;129(Pt 6):1385-98
pubmed: 16613895
Cortex. 2015 Aug;69:220-36
pubmed: 26103600
J Am Geriatr Soc. 2005 Apr;53(4):695-9
pubmed: 15817019
J Commun Disord. 2014 Sep-Oct;51:43-50
pubmed: 25092638
J Neuropsychol. 2019 Jun;13(2):214-239
pubmed: 29424041
Neurocase. 2005 Aug;11(4):283-96
pubmed: 16093229
Brain. 2014 Oct;137(Pt 10):2783-95
pubmed: 25113789
Brain Lang. 2013 Jun;125(3):245-52
pubmed: 23542727
Neurosci Biobehav Rev. 2018 Sep;92:243-254
pubmed: 29928907
Brain. 2012 May;135(Pt 5):1522-36
pubmed: 22382356
Neurology. 2017 Nov 28;89(22):2271-2279
pubmed: 29093069
Neurocase. 2018 Apr;24(2):111-120
pubmed: 29799310
Brain Lang. 2018 Sep;184:54-65
pubmed: 29980072
J Clin Exp Neuropsychol. 2007 May;29(4):377-84
pubmed: 17497561
Alzheimer Dis Assoc Disord. 2007 Oct-Dec;21(4):S23-30
pubmed: 18090419
Brain Lang. 2017 May;168:84-94
pubmed: 28187331
Neurol Clin Pract. 2021 Jun;11(3):249-255
pubmed: 34484892